Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness
Clinical trial NCT03992716 · TERMINATED
Trial details
- NCT number
- NCT03992716
- Sponsor
- Fresenius Kabi
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-26
- Primary completion
- 2020-03-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.